Medicare Enrolled
Dr. Jon Suleskey, D.O.
Urology Physician · Rochester Hills, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Suleskey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Suleskey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Suleskey
Dr. Jon Suleskey is an urology physician in Rochester Hills, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Suleskey performed 6,973 Medicare services across 4,504 unique beneficiaries.
Between the years covered by Open Payments, Dr. Suleskey received a total of $5,080 from 47 pharmaceutical and/or device companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Suleskey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 7% volume in MI
$5,080 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,973
Medicare services
Top 7% in MI for urology physician
4,504
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~349 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
2,031 | $4 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,371 | $61 | $214 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
625 | $8 | $65 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
480 | $88 | $259 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
440 | $8 | $65 |
| PSA test (prostate cancer screening) | 385 | $18 | $121 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
231 | $173 | $768 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
196 | $132 | $352 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
123 | $111 | $400 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
117 | $42 | $119 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
116 | $18 | $121 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
114 | $3 | $15 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
114 | $68 | $270 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 114 | $134 | $799 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
99 | $61 | $194 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
55 | $92 | $266 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
50 | $44 | $303 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
45 | $19 | $121 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
33 | $147 | $2,990 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
31 | $26 | $121 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
30 | $109 | $636 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
29 | $19 | $424 |
| Endoscopic destruction of bladder, urethra, or gland tissue A procedure that uses an endoscope to destroy tissue in the bladder, urethra, or surrounding glands. |
25 | $75 | $2,952 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
25 | $80 | $424 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
23 | $25 | $200 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
21 | $316 | $4,950 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
21 | $10 | $61 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
18 | $252 | $924 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
11 | $174 | $817 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
11.1% medium
88.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,080
Total received (2018-2024)
Avg $726/year across 7 years
Top 33% in MI for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
250
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,985 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$95 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$976
2023
$1,279
2022
$612
2021
$718
2020
$204
2019
$666
2018
$625
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$133
Sumitomo Pharma America, Inc.
$117
PROGENICS PHARMACEUTICALS, INC.
$100
Teleflex LLC
$89
Janssen Biotech, Inc.
$75
Blue Earth Diagnostics Limited
$67
PROCEPT BioRobotics Corporation
$60
Valencia Technologies Corporation
$53
Bayer Healthcare Pharmaceuticals Inc.
$51
ABBVIE INC.
$50
Merck Sharp & Dohme LLC
$44
Cook Medical LLC
$39
ACCORD HEALTHCARE, INC.
$37
Boston Scientific Corporation
$35
AngioDynamics, Inc.
$27
Top 3 companies account for 35.8% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$994
Janssen Biotech, Inc.
$615
Sumitomo Pharma America, Inc.
$372
PFIZER INC.
$362
Myovant Sciences Inc.
$232
Coloplast Corp
$174
Endo Pharmaceuticals Inc.
$160
Bayer Healthcare Pharmaceuticals Inc.
$148
Teleflex LLC
$144
Merck Sharp & Dohme LLC
$112
Blue Earth Diagnostics Limited
$102
PROGENICS PHARMACEUTICALS, INC.
$100
ABBVIE INC.
$98
ACCORD HEALTHCARE, INC.
$90
Bayer HealthCare Pharmaceuticals Inc.
$85
TOLMAR Pharmaceuticals, Inc.
$82
Sunovion Pharmaceuticals Inc.
$78
Boston Scientific Corporation
$73
Amgen Inc.
$69
Allergan, Inc.
$63
180 Medical, Inc.
$61
PROCEPT BioRobotics Corporation
$60
C. R. Bard, Inc. & Subsidiaries
$59
BOSTON SCIENTIFIC CORPORATION
$59
Cook Medical LLC
$54
Valencia Technologies Corporation
$53
Baxter Healthcare
$49
AbbVie Inc.
$44
Bard Access Systems, Inc.
$42
ConvaTec Inc.
$41
Axonics, Inc.
$41
Dendreon Pharmaceuticals LLC
$39
Ambu Inc.
$31
Photocure Inc
$31
Mission Pharmacal Company
$29
AngioDynamics, Inc.
$27
Analogic Corporation
$27
Laborie Medical Technologies Corp.
$24
Myriad Genetic Laboratories, Inc.
$24
Rochester Medical Corporation
$24
Avadel Specialty Pharmaceuticals, LLC
$22
AMAG Pharmaceuticals, Inc.
$20
Retrophin, Inc.
$15
Travere Therapeutics, Inc.
$14
COLOPLAST CORP
$13
DENTSPLY IH Inc.
$13
Allergan Inc.
$12
Top 3 companies account for 39.0% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM SYSTEM · AVEED · AVYCAZ · Altis · Aquoral · Axumin · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · COOK · COOK MEDICAL EXTRACTORS · CYSVIEW · Cysview · ELIGARD · ERLEADA · Erleada · Escape · FLOSEAL · GEMTESA · GENERAL THERAPIES · GENERAL BPH · GENERAL BPH · GENTLECATH · GENTLECATH GLIDE · INTRAROSA · KEYTRUDA · LUPRON DEPOT · LYNX · LoFric · MYRBETRIQ · Myrbetriq · NANOKNIFE · Noctiva · Nubeqa · ORGOVYX · POSLUMA · PROVENGE · PYLARIFY · Prolaris · Prolia · RESONANCE · SPEEDICATH · TITAN · Thiola · UPHOLD LITE · UROLIFT · UroLift System · VESICARE · XGEVA · XIAFLEX · XTANDI · Xtandi · ZYTIGA · eCoin Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
156
Per 100K population
12.3
County median income
$95,296
Nearest hospital
ASCENSION PROVIDENCE ROCHESTER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Suleskey is a clinical cardiology specialist, with above-average Medicare volume (top 7% in MI), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Suleskey experienced with manual urinalysis with microscopic examination?
Based on Medicare claims data, Dr. Suleskey performed 2,031 manual urinalysis with microscopic examination services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Suleskey receive payments from pharmaceutical companies?
Yes. Dr. Suleskey received a total of $5,080 from 47 companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Suleskey's costs compare to other urology physicians in Rochester Hills?
Dr. Suleskey's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Suleskey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Rochester Hills
Browse urology physicians in Rochester Hills ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MI
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MI
Which MI urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology